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 Material and Methods 
Generation of scFv EP2-19G2 mutants and protein purification 
The mutant scFv gene fragments were generated using standard site-directed mutagenesis PCR 
protocols using the wild-type EP2-19G2 scFv gene as template. The obtained scFv genes were 
subcloned into pET-Flag (derived from pET-15b, Novagen) and transformed into Escherichia 
coli BL21(DE3). Expression was induced with 0.5 mM isopropyl β-D-thiogalactoside, and 
FLAG-tagged scFv fragments were purified on anti-Flag mAb M2 affinity agarose (Sigma). 
Steady-state spectral measurements 
Absorption spectra were measured on a HP 8453 spectrometer in PBS (10 mM sodium 
phosphate, 150 mM NaCl, pH 7.4), 3% DMF cosolvent, at 21 °C. The dissolved oxygen was not 
purged. For all the absorption measurements, the concentration of hapten 1 was kept at 10 μM in 
the presence of excess antibody combining sites. The absorption spectra of the EP2-19G2 scFv 
solutions were used as background for correcting the spectra of the corresponding antibody-
hapten complex solutions. Fluorescence spectra were measured on FluoroMax-2 fluorimeter. In a 
typical experiment, the slits were at 1 mm/1 mm, the excitation wavelength was 327 nm, and the 
spectrum was recorded from 350 to 600 nm with an increment of 0.5 nm. The integration time 
was 1 s and the number of iterations was 10. The concentration of 1 was kept at 15 nM and the 
scFv concentrations were kept at around 10 μM. Fluorescence spectra of antibody solutions were 
used as background to correct the fluorescence spectra of corresponding antibody-hapten 
complexes. The fluorescence anisotropies were measured on a PC1 Photon Counting 
Spectrofluorometer from ISS at slit sizes of 1 mm/1 mm. Quantum yields were measured by 
following the instruction at: 
 http://www.jobinyvon.com/usadivisions/Fluorescence/applications/quantumyieldstrad.pdf. The 
standard for the fluorescence quantum yield determinations of the different scFv-1 complexes 
was quinine bisulfate in 0.5 N H2SO4 (Φf =0.546). With the excitation wavelength at 327 nm, the 
fluorescence spectra of different scFv-1 complexes were recorded at the following 
concentrations: 10 nM, 20 nM, 30 nM, 40 nM and 50 nM with integration time 1 s and increment 
of 0.5 nm. The slits were set at 2 mm/3 mm. The fluorescence spectra of quinine bisulfate were 
recorded at concentrations: 10 nM, 20 nM, 30 nM, 40 nM, and 50 nM. The fluorescence spectra 
of the EP2-19G2-1 complexes were recorded at antibody concentrations of 2 μM and EP2 
concentrations of 5, 10, 15, and 20 nM with integration time 1 s and increment of 2 nm. The slits 
were set at 2 mm/3 mm. The Kd values were measured by fluorescence titration. 100, 200, 300, 
400, 500, 600, 700, 1000, 2000, 3000, 4750 nM of the Fab and the scFv fragments were titrated 
against 150 nM and 500 nM of 1 for the Fab and the scFv’s, respectively. The Kd was obtained 
from curve fitting to the one-site binding (hyperbola) equation F = (Fmax * [scFv]) / (Kd + [scFv]) 
with the program GraphPad Prism 5, where F is the measured fluorescence at concentration 
[scFv]. A representative titration curve of the wild-type scFv is shown in Fig. S3. 
Time-resolved spectroscopy 
All time-resolved measurements were made using the time-correlated single-photon counting 
method (S1). Antibody complexes were prepared using 75 μM of scFv’s and 3 μM of 1 in PBS 
(10 mM sodium phosphate, 150 mM NaCl, pH 7.4), with 3% DMF cosolvent. Measurements 
were obtained by using repetitive excitation by a pulsed laser (frequency-tripled output of a 
Coherent Mira Titanium-Sapphire laser, ca. 2 ps pulse width, and repetition rate of 3.8 MHz at 
303 nm). Fluorescence emission was measured at right angles to the excitation beam and by 
using a polarizer set at the magic angle (54.7 relative to vertical). Emission was detected at 410 
 nm by using a microchannel plate photomultiplier (Hamamatsu R3809U-01) and standard time-
correlated, single-photon counting electronics. Emission decays were recorded in 4096 channels 
with a time increment of 22 ps, and were normalized relative to the number of counts recorded in 
the peak channel (approximately 50,000). The instrument response function was recorded using 
scattered light (303 nm) from a dilute suspension of nondairy coffee creamer. Emission decays 
were fit using non-linear least squares regression following convolution of the fitting function 
with the instrument response function. A sum of one or more exponentials was used for the 
fitting function and the goodness of fit was determined by examination of χ2 and of the weighted 
residuals. The intensity decays of the antibody-1 complexes measured at each wavelength could 
only be satisfactorily fit by multi-exponential decays: I(t) = S Σi αi exp(-t/τi), convoluted with the 
instrument response function, where S, αi, and τi are the overall scaling factor, decay amplitude, 
and decay time of component i (Table S1).  
Crystallography 
Fab EP2-25C10 was produced by papain digest as previously described (S2). Crystallization 
experiments were performed by the sitting drop vapor diffusion method at 22.5°C. The Fab, 
concentrated to 15mg/ml in 50 mM acetate buffer pH 5.5, was crystallized in presence of 2-fold 
molar excess of stilbene derivative 1 from 1.5M (NH4)2SO4, 0.2M Li2SO4, 0.1M Tris pH 7.0. For 
data collection, the crystal was flash-cooled to 100K using 25% glycerol as a cryoprotectant. 
Data were collected at the ALS synchrotron/ Berkeley on beamline 5.0.1 and processed and 
scaled with HKL2000 (Table S2) (S3). The structure of EP2-25C10 was determined by 
molecular replacement using the program Phaser (S4) and the coordinates of antibody HyHel 10 
(PDB ID code 3HFM). The model was refined by alternating cycles of model building with the 
program O (S5) and refinement with Refmac5 (S6). During refinement, non-crystallographic 
 symmetry restraints were applied to all main-chain atoms in the two Fab molecules in the 
asymmetric unit, except for some loop regions. The final statistics are shown in Table S2. The 
quality of the structure was analyzed using the programs MolProbity (S7), WHAT IF (S8), and 
PROCHECK (S9). Figures 2 and 4 were prepared with PyMol (S10), and Figure 3 was prepared 
using Bobscript (S11). The coordinates and the structure factors are deposited at the PDB under 
accession code 2NZR. 
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Figure S1. Fluorescence spectra of scFv mutants in complex with 1, recorded in PBS buffer at 
room temperature. Excitation was at 327 nm. Note that the discrepancy in the intensities of some 
samples (e.g. scFv TrpH103Phe) with respect to Fig. 1B is caused by varying protein 
concentrations of the scFv proteins during this initial screening. 
 
 
Figure S2. EPR spectrum of a sample containing ~100 µM EP2-19G2-1 and excess 
[Co(NH3)5Cl]2+ (KPi, 40 K, 6 µW, mod. amplitude 1 G) measured after photolyis/freezing (blue 
 trace), and EPR spectrum of a similar sample that did not contain Co(III) quencher (red trace). 
The hyperfine structure bears the typical signature of a tyrosyl radical that may be generated by 
the oxidized TrpH103 of the charge-transfer complex in the excited state. Note that the lineshapes 
in absence and presence of Co(III) match (right panel), thereby suggesting that a tyrosyl radical 
is formed in both cases.  
 
 
 
Figure S3. Fluorescence titration of the wild-type scFv of EP2-19G2 with 1 for Kd 
determination. 
 
 
 
 
 
 Supporting Tables  
Table S1. Time-resolved fluorescence data of 1 and EP2-19G2-1 complexes. 
  α1 τ1 (ns) α2 τ2 
(ns) 
α3 τ3 
(ns) 
α4 τ4 
(ps) 
1 1 0.0502       
Fab-1 0.331 22.8 0.0648 6.4 0.0988 0.762 0.506 24.5 
scFv wt-1 0.170 22.7 0.0356 6.1 0.0743 0.754 0.720 45.1 
scFv TrpH103Phe-1 0.0009 15.6 0.5867 1.381 0.412 52.4   
scFv TyrL34Phe-1 0.022 34.5 0.0075 4.1 0.0382 0.772 0.932 50.5 
scFv TyrL36Phe-1 0.273 30.3 0.0392 6.3 0.0848 0.882 0.603 46.2 
 
 
 
 
Table S2. Data collection and refinement statistics of Fab EP2-25C10-1. 
 Fab EP2-25C10-1  
Space group P1 
Unit cell dimensions (Å) a=60.0, b=72.5, c=77.2 α=92.0º, β=106.1º, γ=114.2º 
Resolution range (Å) 30.0-2.50 (2.56-2.50) * 
Unique reflections 37,156 
Completeness (%) 97.9 (97.4) 
Redundancy 1.9 (1.9) 
Rsym† 0.08 (0.53) 
<I/σ> 11.1 (1.6) 
Rcryst‡/ Rfree‡ 0.212/0.243 
 Fabs in asymmetric unit 2 
Rmsd¶ from ideal bond 
lengths (Å)/ angles (º) 0.013/ 1.3 
Average B-values protein/ 
water/ stilbene (Å2) 40.2/ 30.9/ 34.8 
Ramachandran plot most 
favored/ additionally allowed/ 
generously allowed/ 
disallowed|| (%)  
89.7/9.2/0.3/0.8 
* Highest resolution shell. 
† Rsym = 100×ΣhklΣi | | Fi(hkl) | - | <Fi(hkl)> | | / ΣhΣi | Fi(hkl) | 
 ‡ Rcryst = 100×Σhkl | | Fc(hkl)| - |Fo(hkl)|| / Σhkl | Fo(hkl) | 
§ Rfree is calculated as for Rcryst, but from 5% of the data that was not used for refinement. 
¶ Root-mean-square deviation. 
|| ThrL51, TyrH33, and AsnH99 of both Fab EP2-25C10 molecules are the only residues in the  
disallowed region, but they all have well-defined electron density. ThrL51 is in a well-defined γ-
turn, as in almost all other antibodies (S12). 
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Online Movie 
Movie S1. Addition of antibody EP2-19G2 to a solution of the stilbene hapten 1 under UV 
illumination illustrates the striking difference between the faint purple fluorescence of 1 in 
absence of antibody and the intense powder-blue luminescence of the antibody-stilbene complex. 
 
 
